Glukolos

Glukolos

gliclazide

Manufacturer:

Sanbe
Concise Prescribing Info
Contents
Gliclazide
Indications/Uses
Diabetes w/ or w/o obesity in adults, elderly & w/ vascular complications.
Dosage/Direction for Use
Initially 40-80 mg daily, gradually increased until adequate control is achieved. Max: 320 mg daily. Doses >160 mg daily are given in 2 divided doses.
Administration
Should be taken with food.
Contraindications
Juvenile diabetics; IDDM w/ ketosis & acidosis; hypersensitivity to sulphonylurea; diabetics during post severe traumatic operation or during infection; diabetic precoma & coma; presence of liver & renal impairment. Pregnant women.
Special Precautions
May be given concomitantly w/ anticoagulants provided regular haematological exam is taken; reduce dose in renal insufficiency; hepatic dysfunction, hypoglycemia.
Adverse Reactions
Hypoglycemia. GI disturbances eg, nausea, vomiting, diarrhea, epigastric fullness & gastric irritation. Dermatologic reactions eg, allergy, pruritus, erythema, urticaria. Rarely, haematologic reactions eg, leukopenia, agranulocytosis, thrombocytopenia & anemia.
Drug Interactions
Long-acting sulfonamides, tuberculostatics, phenylbutazone, clofibrate, MAOIs, coumarin derivatives, salicylates, probenecid, propranolol, miconazole, cimetidine, ACE inhibitors may increase hypoglycemic effects of gliclazide. Diuretics (thiazides & furosemide), corticosteroids, OCs (estrogen + progestogen) & nicotinic acid may induce hyperglycemia. Barbiturates may reduce hypoglycemic effect.
MIMS Class
Antidiabetic Agents
ATC Classification
A10BB09 - gliclazide ; Belongs to the class of sulfonylureas. Used in the treatment of diabetes.
Presentation/Packing
Form
Glukolos tab 80 mg
Packing/Price
10 × 10's (Rp232,500/boks)
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in